CANTATA MICROCATHETER

K101450 · Cook, Inc. · KRA · Dec 30, 2010 · Cardiovascular

Device Facts

Record IDK101450
Device NameCANTATA MICROCATHETER
ApplicantCook, Inc.
Product CodeKRA · Cardiovascular
Decision DateDec 30, 2010
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 870.1210
Device ClassClass 2
AttributesTherapeutic

Intended Use

The Cantata™ Microcatheter is designed for use in small vessel or superselective anatomy for diagnostic and interventional procedures including neuro, peripheral, or coronary use.

Device Story

Cantata™ Microcatheter is an infusion catheter for diagnostic and interventional procedures in small vessel or superselective anatomy (neuro, peripheral, coronary). Device features hydrophilic coating on 2.5 or 2.8 French shafts (100-150 cm lengths). Supplied sterile for single-use. Operated by physicians in clinical settings to facilitate access to small vessels. Device provides a pathway for infusion or diagnostic access; performance relies on mechanical properties (tensile strength, burst pressure, kink radius) and lubricity of the coating. Benefits include improved navigation and access to complex, small-diameter vascular anatomy.

Clinical Evidence

Bench testing only. Testing included tensile strength, static burst pressure, kink radius, coating durability/lubricity, shelf life, endotoxin/bioburden, and particulate testing. Biocompatibility testing included cytotoxicity, sensitization, intracutaneous reactivity, systemic toxicity, hemolysis, pyrogenicity, complement activation, and ASTM partial thromboplastin time. Rationale provided for omission of in vivo thrombogenicity testing.

Technological Characteristics

Infusion catheter with hydrophilic coating. Available in 2.5 and 2.8 French shaft diameters and 100, 110, 135, and 150 cm lengths. Sterile, single-use. Biocompatibility testing per ISO/ASTM standards. Mechanical testing includes tensile strength, static burst pressure, and kink radius.

Indications for Use

Indicated for patients requiring diagnostic or interventional procedures in small vessel or superselective anatomy, including neuro, peripheral, or coronary vasculature.

Regulatory Classification

Identification

A continuous flush catheter is an attachment to a catheter-transducer system that permits continuous intravascular flushing at a slow infusion rate for the purpose of eliminating clotting, back-leakage, and waveform damping.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Special 510(k) Premarket Notification CantataTM Microcatheter COOK INCORPORATED #### 510(k) Summary # K101450 # DEC 300 2010 . ### Submitted By: Mironda Carpenter Regulatory Affairs Specialist Cook Incorporated 750 Daniels Way, P.O. Box 489 Bloomington, IN 47402 812.339.2235 22 December 2010 #### Device: Trade Name: Proposed Classification: Cantata™ Microcatheter Catheter, Continuous Flush KRA #### Indications for Use: The Cantata™ Microcatheter is designed for use in small vessel or superselective anatomy for diagnostic and interventional procedures including neuro, peripheral, or coronary use. # Predicate Devices: The Cantata™ Microcatheter is identical in terms of intended use and technological characteristics and similar in terms of material with the predicate MiraFlex®18 Microcatheter cleared under 510(k) number K060224 and the MiraFlex® High Flow Microcatheter cleared under 510(k) number K080737. The change involves a conversion from the current hydrophilic coating to a differently formulated hydrophilic coating. #### Device Description: The Cantata™ Microcatheter is an infusion catheter with a hydrophilic coating, designed for use in small vessel or superselective anatomy for diagnostic and interventional procedures. The device is available in 2.5 and 2.8 French shafts and is available in 100, 110, 135, and 150 cm lengths. The device is supplied sterile and intended for one-time use. {1}------------------------------------------------ # Substantial Equivalence: The Cantata™ Microcatheter is substantially equivalent to the predicate MiraFlex®18 Microcatheter cleared under 510(k) number K060224 and MiraFlex® High Flow Microcatheter cleared under 510(k) number K080737. # Test Data: The Cantata™ Microcatheter was subjected to the following tests to assure reliable design and performance under the specified testing parameters. These tests were: - 1. Tensile strength - 2. Static burst pressure - 3. Kink radius - 4. Coating durability and lubricity - 5. Biocompatibility - a. Cytotoxicity - b. Sensitization, Maximization - c. Intracutaneous - d. Systemic Toxicity - e. Hemolysis - f. Pyrogen - g. Complement Activation - h. ASTM Partial Thromboplastin Time - 6. Shelf life - 7. Endotoxin/bioburden - 8. Particulate Testing A rationale based upon the geometry, conditions of use and the materials that interact with the blood was submitted to support the omission of the in vivo thrombogenicity testing. The results of these tests provide reasonable assurance that the device has been designed and tested to assure conformance to the requirements for its intended use. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services (HHS). The logo consists of a stylized eagle with three stripes forming its wing, enclosed within a circle. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged around the upper half of the circle. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 Cook Incorporated c/o Ms. Mironda Carpenter Regulatory Affairs Specialist 750 Daniels Wav P.O. Box 489 Bloomington. IN 47402 DEC 3 0 2010 Re: K101450 > Trade/Device Name: Cantata™ Microcatheter Common Name: Catheter, Continuous Flush Regulation Number: 21 CFR 870.1210 Regulatory Class: II Product Code: KRA Dated: December 17, 2010 Received: December 20, 2010 #### Dear Ms. Carpenter: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ Page 2 - Ms. Mironda Carpenter Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH0ffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ Special 510(k) Premarket Notification Cantata™M Microcatheter COOK INCORPORATED 21-May-2010 # Indications for Use DEC 3 0 2010 510(k) Number (if known): _ Kl (0145D Device Name: Cantata™ Microcatheter The Cantata™ Microcatheter is designed for use in small vessel or Indications for Use: superselective anatomy for diagnostic and interventional procedures including neuro, peripheral, or coronary use. Prescription Use X (Per 21 CFR 801 Subpart D) OR Over-the-Counter Use (Per 21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) diovascular Devices 510(k) Number : K101450 5 il :
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%